Science Explorer Interactive view Map

ObeTherapy Biotechnology (France)

Research works
3
▼ 83% vs 2013–17
Citations
36
12.0 per fractional work
Top-10% rate
1.7%
record average 16.5%
Open access
24%
world 28%

Not ranked overall: ObeTherapy Biotechnology (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does ObeTherapy Biotechnology (France) publish most on?

By volume: Pancreatic function and diabetes, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer and Head and Neck Cancer Studies.

  1. 1 Pancreatic function and diabetes Surgery 0 works
  2. 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
  4. 4 Head and Neck Cancer Studies Otorhinolaryngology 0 works
  5. 5 Bariatric Surgery and Outcomes Surgery 0 works
  6. 6 Diet and metabolism studies Physiology 0 works
  7. 7 Ear and Head Tumors Oncology 0 works
  8. 8 Salivary Gland Tumors Diagnosis and Treatment Surgery 0 works
  9. 9 Peptidase Inhibition and Analysis Oncology 0 works
  10. 10 Adipose Tissue and Metabolism Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.5%not open76.5%

World: 28% of research is openly available.

with international co-authors37.1%domestic only62.9%

World: 19% is written across borders.

How has ObeTherapy Biotechnology (France)'s research output changed?

Output in 2018–2022 was 83% lower than in 2013–2017.

2000200520102015
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Évry-Courcouronnes

All research institutions in Évry-Courcouronnes

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.